News
The EDCTP Prizes are open for submissions from 11 March until 1 April 2025 via the Funding and Tenders Portal. Deadline to apply is on 1 April, 17:00 CET.
The EDCTP Prizes will recognise outstanding individuals and research teams from Africa and Europe who have made significant achievements in their research field. Additionally, the awardees will have made major contributions to strengthening clinical research capacity in Africa and supporting South-South and North-South networking. The Prizes will be awarded during the Twelfth EDCTP Forum, taking place on 15-20 June 2025 in Kigali, Rwanda.
Contrary to previous editions, applications for the EDCTP Prizes 2025 are to be submitted by the individuals or teams applying for the Prizes, with supporting letter(s) of recommendation from at least one reputable scientist.
Find out more on the dedicated EDCTP3 webpage and read the Rules of Contest.
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP) Association whose members are several EU Member States and Associated countries and several African countries.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
ESA Space Solutions has opened a call for proposals on space-enabled solutions for resilient electricity grids, in collaboration with ENTSO-E. The call supports proof-of-concept studies and pilot projects that address challenges in grid resilience and operational continuity.
Read moreThe Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.
Read moreThe launch of the 2027 calls for proposals under the Defence-related Research Action (DEFRA) programme has been postponed until Spring 2027. As a result, the information days initially scheduled for 23 and 24 November 2026 will also be postponed. A revised timeline will be communicated as soon as it becomes available.
Read moreThe European Partnership for Personalised Medicine (EP PerMed) is about to launch the joint transnational call 2027 (JTC2027) “Cell and Gene Therapy for Personalised Medicine”. The call opens on 4 November 2026.Proposals must focus on the development and validation of an innovative and novel cell and gene therapy for...
Read moreTestimonial
Funded under Horizon Europe (HORIZON-INFRA-2024-TECH-01-03) and running from 2025 to 2028, UrbanAIR develops advanced digital twins that simulate the interactions between urban climate, human behaviour, and policy choices. These models enable cities to explore what-if scenarios, such as new green infrastructure, mobility measures or building designs, and assess their impacts on health, safety and social equity. The project consortium consists of 18 partners from 11 countries. Read more about the project and the contribution of Flemish partner Vito in this testimonial.
